Partnering focus areas
We are an innovative medicines focused company working on four therapeutic areas and five technology platforms.
With global biomedical innovation moving at an unparalleled pace, partnering fuels scientific progress and patient care. At Novartis, we're collaborating with innovators to address some of society's most challenging healthcare issues.
>50%
of our revenue comes from external innovation
140+
countries where Novartis products are sold
>$10B
invested in R&D in 2022
Technology Platforms
Partnering - Biotherapeutics
We strive to leverage cutting-edge science and technology to create novel biotherapeutics that deliver transformative impact in healthcare, and we are dedicated to advancing the production of high-quality biologics, with the goal of ultimately bringing safe and effective treatments to patients in need.
Partnering is at the core of our business
We collaborate to address some of society s most challenging healthcare issues and have a unified partnering strategy fueled by clarity, agility, accountability, and efficiency.
